MRAM

Rating neutralAI Memo

Everspin

As of 2026-04-29/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-04-29 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Q1 2026 earnings is the immediate proof point, but results were not yet visible in company sources as of April 29, 2026 • 2026-04-29

Expected move: -52%

Biggest risk

The cautious case is that the scheduled Q1 follow-up still lacked a visible company results release at the time checked, the Microchip expansion introduces meaningful execution and reimbursement commitments, and several forward hooks are still issuer-driven rather than validated by broad external adoption evidence. [#IR-2026-04-15][#8-K-2026-04-10]

Invalidation

Break below $11 or thesis failure.

What would change my mind?

The constructive case is that FY2025 ended with 238 design wins expected to ramp in 2026-2027, Q1 had a prior revenue guide of $14.0-$15.0 million, and the recent xSPI and UNISYST announcements give dated product and platform checkpoints instead of a purely thematic memory story. [#IR-2026-03-04][#10-K-2026-03-04][#IR-2026-03-05][#IR-2026-03-10]

Research note

Recommendation

neutral

Confidence

medium

As of

2026-04-29

Base target

$13

p=47%

Bull target

$15

p=28%

Bear target

$11

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

xSPI qualification milestones create dated 2026 product-ramp checkpoints
Microchip agreement broadens on-shore capacity but raises execution and cash-commitment risk
The constructive case is that FY2025 ended with 238 design wins expected to ramp in 2026-2027, Q1 had a prior revenue guide of $14.0-$15.0 million, and the recent xSPI and UNISYST announcements give dated product and platform checkpoints instead of a purely thematic memory story.

BearKey bullets

As of April 29, 2026, the checked company sources showed the Q1 2026 earnings date notice but not yet a visible results release or 8-K exhibit, limiting conviction on any post-earnings interpretation.
Peer and analyst coverage are thin, so sentiment can swing on issuer-led headlines with limited external validation.
Product-roadmap risk remains real because the 128Mb and 256Mb xSPI qualification milestones are still ahead; a slip would undercut the 2H 2026 commercialization case.

WatchKey bullets

Q1 2026 earnings is the immediate proof point, but results were not yet visible in company sources as of April 29, 2026

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $13 (p=47%)

Bull/Bear spread: -43% / -60%

Vs latest close: Bull -43% · Base -52% · Bear -60%

Scenario probabilities

Bull Target: $15 (p=28%)Base Target: $13 (p=47%)Bear Target: $11 (p=25%)

Commentary

Headline tone over the last month is constructive because it is dominated by company releases on capacity expansion, xSPI qualification progress and the UNISYST launch. But this earnings follow-up remains tentative: as of April 29, 2026, the company-source evidence checked confirmed the scheduled earnings timing, not a posted Q1 results release, so earnings surprise data, analyst revisions and true post-print market reaction were unavailable for this run. With low coverage, sparse targets and the stock already near the packet median target, sentiment stays cautious-monitoring rather than bullish.

As of 2026-04-29 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

xSPI qualification milestones create dated 2026 product-ramp checkpoints
Microchip agreement broadens on-shore capacity but raises execution and cash-commitment risk

Scenarios

Bull Target (Scenario probability)

$15 / p=28% prob

Base Target (Scenario probability)

$13 / p=47% prob

Bear Target (Scenario probability)

$11 / p=25% prob

Price $26 as of 2026-05-29

Nearest Scenario: Bull (∆ 43%)

Targets vs latest close: Bull -43% · Base -52% · Bear -60%

Sentiment & Exposure

News Sentiment (30d)

0.24

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-04-29
Q1 2026 earnings is the immediate proof point, but results were not yet visible in company sources as of April 29, 2026
Everspin said it would release first-quarter 2026 financial results after market close on April 29, 2026, and its March 4 release guided to Q1 revenue of $14.0-$15.0 million with GAAP EPS between a $0.03 loss and $0.02 income. As of this run, the company-source evidence checked still showed the scheduling notice rather than the results release, so the near-term setup remains a monitoring event rather than a confirmed beat or miss. [#IR-2026-04-15][#IR-2026-03-04]
Prob 70.00% • Move 8.00% • Priced-in 60.00%

Short-term Catalysts

Next few weeks

No short-term catalysts

Long-term Catalysts

Months to a year

xSPI qualification milestones create dated 2026 product-ramp checkpoints
2026-07-31
Everspin said its 64Mb HR xSPI STT-MRAM completed full production qualification, with the 128Mb part expected to complete qualification in May 2026 and the 256Mb option in July 2026, with volume availability expected in 2H 2026. Those dated milestones are more tangible than a generic semiconductor-demand thesis, but any slip would weaken the commercialization narrative. [#IR-2026-03-05]
Prob 65% • Move 12% • Priced-in 45%
Microchip agreement broadens on-shore capacity but raises execution and cash-commitment risk
2027-09-30
The Microchip manufacturing agreement adds a second on-shore source and Everspin said first products from the collaboration are expected in 2H 2027, but the related 8-K said Everspin will reimburse Microchip about $13.95 million in two phases for relocation, installation, tooling and qualification costs. That supports supply resilience, yet it also adds a real execution and capital-absorption test for a company of MRAM's size. [#8-K-2026-04-10][#IR-2026-04-08]
Prob 60% • Move 14% • Priced-in 35%

Risks

As of April 29, 2026, the checked company sources showed the Q1 2026 earnings date notice but not yet a visible results release or 8-K exhibit, limiting conviction on any post-earnings interpretation.
Peer and analyst coverage are thin, so sentiment can swing on issuer-led headlines with limited external validation.
Product-roadmap risk remains real because the 128Mb and 256Mb xSPI qualification milestones are still ahead; a slip would undercut the 2H 2026 commercialization case. [#IR-2026-03-05]
The Microchip manufacturing expansion carries meaningful execution risk, including qualification timing, process transfer risk, and roughly $13.95 million of reimbursement obligations. [#8-K-2026-04-10]

Peers

Symbol	Summary
GSIT	GSI Technology is the closest small-cap memory-oriented peer in the packet; both depend on niche-memory adoption and customer program conversion more than broad platform scale.
ASYS	Amtech Systems is a looser but still useful small-cap semiconductor manufacturing-execution comp, especially for judging how much operational slippage a subscale hardware name can absorb.
BZAI	Blaize is only an adjacency comp through edge-AI exposure, which reinforces that MRAM's true public-peer set is thin and lowers comparative confidence.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-04-29

AI Stock Memo: MRAM - Everspin - RankAlpha